Pharmacon Limited
Pharmacon Limited, a leading name in the pharmaceutical industry, is headquartered in Bangladesh (BD) and operates extensively across South Asia. Founded in 2001, the company has established itself as a key player in the development and manufacturing of high-quality generic medicines and active pharmaceutical ingredients (APIs). Pharmacon Limited is renowned for its commitment to innovation and quality, offering a diverse range of products that cater to various therapeutic areas, including cardiology, oncology, and infectious diseases. The company’s state-of-the-art facilities and adherence to international regulatory standards set it apart in a competitive market. With a strong focus on research and development, Pharmacon Limited has achieved significant milestones, positioning itself as a trusted partner in healthcare. Its dedication to excellence has earned recognition both locally and internationally, solidifying its reputation as a reliable source of pharmaceutical solutions.
DitchCarbon Score
How does Pharmacon Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmacon Limited's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmacon Limited's reported carbon emissions
Pharmacon Limited, headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Pharmacon Limited may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate change impacts. However, without specific emissions data or commitments, it is unclear how Pharmacon Limited aligns with these industry standards. As the global focus on climate action intensifies, it will be essential for Pharmacon Limited to consider developing measurable targets and strategies to address its environmental impact in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmacon Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
